Eli Lilly and Company (LLY) - Yahoo Finance

Find the latest Eli Lilly and Company (LLY) stock quote, history, news and other vital information to help you with your stock trading and investing.

5%
OFF

Eli Lilly Shares Down 7.5% As Market Reacts To Slashed Q4 Forecast

2 weeks from now

16 hours ago · Shares of Eli Lilly (NYSE:LLY) are down 7.6% today, reflecting market disappointment in the company's adjusted guidance for the fourth quarter of 2024. The …

yahoo.com

$1000
OFF

Eli Lilly Stock Upgraded To "Buy" As Analysts Boost ... - Yahoo …

2 weeks from now

Jan 2, 2025 · A number of other companies have also reaffirmed their belief in Eli Lilly's stock. Truist Financial added its predicted price to improve from $1,000 to $1,033, delivering a 'buy,' …

yahoo.com

$3
OFF

Should Investors Buy Eli Lilly's (LLY) Stock After Strong Q2 Results?

2 weeks from now

Aug 12, 2024 · Eli Lilly’s Q2 Results Led by MOUNJARO and ZEPBOUND, Eli Lilly’s type-2 diabetes and weight loss drug, the company stated its new product sales grew by nearly $3.5 …

yahoo.com

3%
OFF

Eli Lilly (LLY) Stock Declines While Market Improves: Some …

2 weeks from now

1 day ago · Eli Lilly (LLY) ended the recent trading session at $797.48, demonstrating a -0.3% swing from the preceding day's closing price. The stock fell short of the S&P 500, which …

yahoo.com

5%
OFF

Why Eli Lilly (LLY) Stock Is Declining Today - Yahoo Finance

2 weeks from now

17 hours ago · The shares of pharmaceutical giant Eli Lilly (LLY) are falling 5% today after the company preannounced lower-than-expected fourth-quarter revenue. The firm estimated that it …

yahoo.com

20%
OFF

Down More Than 20% From Its High, Is Now The Time To Buy Eli …

2 weeks from now

Nov 28, 2024 · Eli Lilly (LLY 1.61%) is the most valuable healthcare stock in the world, with a market capitalization of nearly $700 billion. But in recent weeks, its share price has been …

fool.com

16%
OFF

Is Eli Lilly Stock A Buy? - The Motley Fool

2 weeks from now

Jul 28, 2024 · Weight loss drugs, primarily GLP-1 agonists, have taken the healthcare industry and the stock market by storm. Leading pharmaceutical company Eli Lilly (LLY-2.16%) is a …

fool.com

10%
OFF

Is Now A Good Time To Buy The Dip In Eli Lilly Stock?

2 weeks from now

Nov 21, 2024 · Owning shares of pharmaceutical giant Eli Lilly (LLY-0.10%) has generally been a great idea over the past year. Lilly's diabetes medication Mounjaro and its sibling treatment for …

fool.com

$2
OFF

Eli Lilly To Buy Cancer Drug Developer Scorpion Therapeutics For …

2 weeks from now

1 day ago · Eli Lilly to buy cancer drug developer Scorpion Therapeutics for $2.5 billion FILE PHOTO: The logo and ticker for Eli Lilly and Co are displayed on a screen on the floor of the …

yahoo.com

FAQs about Eli Lilly and Company (LLY) - Yahoo Finance Coupon?

Is Eli Lilly stock a buy?

Powered by its popular GLP-1 weight loss drugs, Eli Lilly 's stock (NYSE: LLY) has had a strong run this year, up more than 55%. However, the company's success goes back much further, with the stock up more than 1,300% over the past decade. ...

Why is Eli Lilly (LLY) stock down?

Eli Lilly and Company (LLY) stock is down in Wednesday's premarket trading after the pharmaceutical company reported third quarter results that missed revenue expectations. The disappointing performance was driven by lower-than-anticipated sales of the company's weight loss drug, Zepbound. ...

Should you buy Eli Lilly (LLY)?

Leading pharmaceutical company Eli Lilly (NYSE: LLY) is a significant player in the space, helping explain why the stock has soared 250% over the past three years. Investors who may want to buy shares have been left wondering if they're too late, or if there's more to Lilly than its headline-grabbing GLP-1 products. ...

Is Lilly a good stock to buy?

Lilly offers robust growth prospects at a good price, and the stock's recent sell-off presents a great buying opportunity for long-term investors, in my view. Keith Speights has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. ...

Is Eli Lilly a 'buy' or 'hold' in 2025?

Of the 23 covering Eli Lilly analysts, 18 rate it a 'buy,' and 4 remain at 'hold.' With continued growth plans underway ahead of the company expanding its portfolio, 2025 and beyond is seen as positive for Eli Lilly investors and analysts alike, who continue to expect strong performance from the pharmaceutical firm. ...

How much will Eli Lilly sell in 2024?

Between the two, 2024 sales could realistically surpass $10 billion. Analysts believe the total GLP-1 market will approach $50 billion this year, meaning Eli Lilly has around 20% market share -- despite an ongoing GLP-1 shortage that's temporarily allowing pharmacies to sell compounded alternatives outside patent restrictions. ...